These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9118461

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Phase I/pharmacokinetic study of topotecan by 24-hour continuous infusion weekly.
    Haas NB, LaCreta FP, Walczak J, Hudes GR, Brennan JM, Ozols RF, O'Dwyer PJ.
    Cancer Res; 1994 Mar 01; 54(5):1220-6. PubMed ID: 8118810
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography.
    Takimoto CH, Klecker RW, Dahut WL, Yee LK, Strong JM, Allegra CJ, Grem JL.
    J Chromatogr B Biomed Appl; 1994 Apr 22; 655(1):97-104. PubMed ID: 8061838
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical, pharmacokinetic and biological studies of topotecan.
    O'Dwyer PJ, LaCreta FP, Haas NB, Halbherr T, Frucht H, Goosenberg E, Yao KS.
    Cancer Chemother Pharmacol; 1994 Apr 22; 34 Suppl():S46-52. PubMed ID: 8070027
    [Abstract] [Full Text] [Related]

  • 28. Limited sampling models for topotecan pharmacokinetics.
    van Warmerdam LJ, Verweij J, Rosing H, Schellens JH, Maes RA, Beijnen JH.
    Ann Oncol; 1994 Mar 22; 5(3):259-64. PubMed ID: 8186175
    [Abstract] [Full Text] [Related]

  • 29. The detection of photodegradation products of irinotecan (CPT-11, Campto, Camptosar), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometry.
    Dodds HM, Robert J, Rivory LP.
    J Pharm Biomed Anal; 1998 Aug 22; 17(4-5):785-92. PubMed ID: 9682163
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability.
    Burke TG, Mi Z.
    J Med Chem; 1994 Jan 07; 37(1):40-6. PubMed ID: 8289200
    [Abstract] [Full Text] [Related]

  • 32. Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function.
    O'Reilly S, Rowinsky E, Slichenmyer W, Donehower RC, Forastiere A, Ettinger D, Chen TL, Sartorius S, Bowling K, Smith J, Brubaker A, Lubejko B, Ignacio V, Grochow LB.
    J Natl Cancer Inst; 1996 Jun 19; 88(12):817-24. PubMed ID: 8637048
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer.
    Grochow LB, Rowinsky EK, Johnson R, Ludeman S, Kaufmann SH, McCabe FL, Smith BR, Hurowitz L, DeLisa A, Donehower RC.
    Drug Metab Dispos; 1992 Jun 19; 20(5):706-13. PubMed ID: 1358575
    [Abstract] [Full Text] [Related]

  • 34. No evidence that amifostine influences the plasma pharmacokinetics of topotecan in ovarian cancer patients.
    Zackrisson AL, Malmström H, Peterson C.
    Eur J Clin Pharmacol; 2002 May 19; 58(2):103-8. PubMed ID: 12012141
    [Abstract] [Full Text] [Related]

  • 35. Lack of stability of topotecan in heart tissue homogenates: is it an analytical dilemma or a real phenomenon?
    Srinivas NR.
    Biomed Chromatogr; 2009 Apr 19; 23(4):447-9. PubMed ID: 19016457
    [No Abstract] [Full Text] [Related]

  • 36. Determination of topotecan in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography.
    de Vries NA, Ouwehand M, Buckle T, Beijnen JH, van Tellingen O.
    Biomed Chromatogr; 2007 Nov 19; 21(11):1191-200. PubMed ID: 17582233
    [Abstract] [Full Text] [Related]

  • 37. Phase I and pharmacologic study of topotecan in patients with impaired renal function.
    O'Reilly S, Rowinsky EK, Slichenmyer W, Donehower RC, Forastiere AA, Ettinger DS, Chen TL, Sartorius S, Grochow LB.
    J Clin Oncol; 1996 Dec 19; 14(12):3062-73. PubMed ID: 8955651
    [Abstract] [Full Text] [Related]

  • 38. Sensitive high-performance liquid chromatographic method for the determination of the lactone form and the lactone plus hydroxy-acid forms of the new camptothecin derivative DX-8951 in human plasma using fluorescence detection.
    Oguma T, Ohshima Y, Nakaoka M.
    J Chromatogr B Biomed Sci Appl; 2000 Apr 14; 740(2):237-45. PubMed ID: 10821410
    [Abstract] [Full Text] [Related]

  • 39. Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.
    de Bruijn P, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A.
    J Chromatogr B Biomed Sci Appl; 1997 Sep 26; 698(1-2):277-85. PubMed ID: 9367218
    [Abstract] [Full Text] [Related]

  • 40. Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
    Bansal T, Awasthi A, Jaggi M, Khar RK, Talegaonkar S.
    Talanta; 2008 Sep 15; 76(5):1015-21. PubMed ID: 18761148
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.